Dipender is a clinician scientist, who trained in Medical Sciences at the University of Oxford and was awarded Distinction for his BM BCh. He went on to become a specialist registrar in clinical pharmacology and therapeutics at Imperial College Healthcare NHS Trust, and in 2013 became an Honorary Clinical Lecturer at Imperial College London. Most recently, Dipender has followed his research interests in Mendelian randomisation to identify causal risk factors and therapeutic targets for cardiovascular diseases, successfully defending his PhD thesis in Dec 2019. He has over 50 peer-reviewed manuscripts including 16 first author papers from his PhD. This includes work identifying genetic variants to proxy the effect of antihypertensive, anticoagulant and anti-inflammatory drugs.
et al., 2022, Genetic evidence for protective effects of angiotensin converting enzyme against Alzheimer's disease but not other neurodegenerative diseases in European populations, Neurology Genetics, Vol:8, ISSN:2376-7839
et al., 2022, Sodium-glucose cotransporter 1 inhibition and gout: Mendelian randomisation study, Seminars in Arthritis and Rheumatism, Vol:56, ISSN:0049-0172
et al., 2022, Genetically Predicted Smoking and Alcohol Consumption and Functional Outcome After Ischemic Stroke., Neurology
et al., 2022, Anthropometric Traits and Risk of Mitral Valve Prolapse: A Mendelian Randomization Study., Circ Genom Precis Med
et al., 2022, Genetic risk and incident venous thromboembolism in middle-aged and older adults following COVID-19 vaccination., J Thromb Haemost